NO992665L - Sammensetninger og fremgangsmåter for å administrere pneumokokkisk DNA - Google Patents

Sammensetninger og fremgangsmåter for å administrere pneumokokkisk DNA

Info

Publication number
NO992665L
NO992665L NO992665A NO992665A NO992665L NO 992665 L NO992665 L NO 992665L NO 992665 A NO992665 A NO 992665A NO 992665 A NO992665 A NO 992665A NO 992665 L NO992665 L NO 992665L
Authority
NO
Norway
Prior art keywords
administering
compositions
methods
pneumococcal dna
pneumococcal
Prior art date
Application number
NO992665A
Other languages
English (en)
Other versions
NO992665D0 (no
Inventor
David E Briles
Larry S Mcdaniel
David T Curiel
Original Assignee
Univ Alabama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alabama filed Critical Univ Alabama
Publication of NO992665D0 publication Critical patent/NO992665D0/no
Publication of NO992665L publication Critical patent/NO992665L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO992665A 1996-12-04 1999-06-02 Sammensetninger og fremgangsmåter for å administrere pneumokokkisk DNA NO992665L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75950596A 1996-12-04 1996-12-04
PCT/US1997/022847 WO1998024927A1 (en) 1996-12-04 1997-12-04 Compositions and methods for administering pneumococcal dna

Publications (2)

Publication Number Publication Date
NO992665D0 NO992665D0 (no) 1999-06-02
NO992665L true NO992665L (no) 1999-08-04

Family

ID=25055905

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992665A NO992665L (no) 1996-12-04 1999-06-02 Sammensetninger og fremgangsmåter for å administrere pneumokokkisk DNA

Country Status (9)

Country Link
US (1) US20020102242A1 (no)
EP (1) EP1019522A4 (no)
JP (1) JP2002514061A (no)
AU (1) AU5523798A (no)
CA (1) CA2274095A1 (no)
IL (1) IL130291A0 (no)
NO (1) NO992665L (no)
WO (1) WO1998024927A1 (no)
ZA (1) ZA9710934B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040219163A1 (en) * 2001-10-03 2004-11-04 Frelinger John G. Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2
WO2010141312A2 (en) 2009-06-01 2010-12-09 Wake Forest University Health Sciences Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
EP2791189B1 (en) 2011-12-14 2018-05-02 Ineos Europe AG Novel polymers
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476929A (en) * 1991-02-15 1995-12-19 Uab Research Foundation Structural gene of pneumococcal protein
FI933580A7 (fi) * 1991-02-15 1993-10-13 Uab Research Foundation Pneumokokkiproteiinin rakennegeeni

Also Published As

Publication number Publication date
EP1019522A4 (en) 2002-06-19
WO1998024927A1 (en) 1998-06-11
JP2002514061A (ja) 2002-05-14
CA2274095A1 (en) 1998-06-11
IL130291A0 (en) 2000-06-01
ZA9710934B (en) 1998-09-10
US20020102242A1 (en) 2002-08-01
AU5523798A (en) 1998-06-29
EP1019522A1 (en) 2000-07-19
NO992665D0 (no) 1999-06-02

Similar Documents

Publication Publication Date Title
IL127545A0 (en) Compositions and methods for administering borrelia DNA
NO973046D0 (no) Elastiske sementsammensetninger og fremgangsmåte
NO973048D0 (no) Elastiske sementsammensetninger og fremgangsmåter
NO985196D0 (no) Dispergerbare makromolekylblandinger og fremgangsmÕter for deres fremstilling og anvendelse
ATE351910T1 (de) Ob-fusionsprotein enthaltende zusammensetzungen und verfahren
GB2331015B (en) Therapeutic methods and compositions involving isoflavones
NO991676L (no) FremgangsmÕter og sammensetninger for immunmodulering
CY2013008I1 (el) Πεπτιδιο κατασταλτικο της ορεξης, συνθεσεις και χρηση αυτου
DE69717853D1 (de) Verpacktes lichthärtbares gemisch
ATE236898T1 (de) S-omeprazol in festform
ID17860A (id) Komposisi vaksin
NO985385L (no) Bitumensammensetninger og fremgangsmÕte for fremstilling derav
IS4466A (is) Samsetning og meðhöndlun fyrir heila- og mænusigg
DE69714504D1 (de) Benzothiopene, diese enthaltende Zubereitungen und Verfahren
NO20004274D0 (no) Proteaseaktivert reseptor 4 og anvendelse derav
NO992665L (no) Sammensetninger og fremgangsmåter for å administrere pneumokokkisk DNA
DK0910369T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder
NO991749D0 (no) Sammensetninger til bruk i betong og betongprodukter fremstilt derav
FI972988A0 (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
ID18698A (id) Komposisi farmasi
ID19246A (id) Komposisi oral antikalkulus
NO973047D0 (no) Elastiske sementsammensetninger og fremgangsmåter
ID19099A (id) Komposisi oral
ITMI962628A0 (it) Composizione farmaceutica
NO952766D0 (no) Opplösningsmiddelsammensetninger og metoder

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application